Live Breaking News & Updates on Otsuka astex

Stay informed with the latest breaking news from Otsuka astex on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Otsuka astex and stay connected to the pulse of your community

Sudo Biosciences Announces Second Close of Upsized Series B Financing Bringing Total Raised in Round

The funding will advance two precision TYK2 inhibitors into the clinic for multiple sclerosis, psoriasis and other severe autoimmune and neurologic conditions.New investors include Dementia Discovery Fund, Leaps by Bayer, and UPMC Enterprises.CARMEL, Ind.--(BUSINESS WIRE)--#TYK2--Sudo Biosciences (“Sudo”), a biophar...

London , City-of , United-kingdom , Boston , Massachusetts , United-states , British , Matthias-kleinz , Sudo-bioscience , Juergen-eckhardt , Scott-byrd , Sudo-biosciences

Dementia Discovery Fund Announces the Acquisition of Caraway Therapeutics by Merck

Dementia Discovery Fund Announces the Acquisition of Caraway Therapeutics by Merck
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

London , City-of , United-kingdom , Alexandria , Al-iskandariyah , Egypt , United-states , Canada , Boston , Massachusetts , British , Tim-harris

AstronauTx closes £48 million ($61 million) Series A financing to create new treatments for Alzheimer's disease

/PRNewswire/ -- AstronauTx Ltd. ("AstronauTx"), a biotech company developing novel treatments for Alzheimer's disease and other neurodegenerative disorders,...

London , City-of , United-kingdom , Denmark , Boston , Massachusetts , United-states , Danish , British , Ruth-mckernan , Astronautx-bio , Bill-gates

Dementia Discovery Fund invests in Amphista Therapeutics as it targets neurodegenerative diseases

/PRNewswire/ -- Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, today announced a Series B extension...

Cambridge , Cambridgeshire , United-kingdom , British , Alessio-ciulli , Christian-jung , Bill-gates , Lynn-granito , Eli-lilly , Otsuka-astex , Nicola-thompson , Amphista-eclipsys

Dementia Discovery Fund invests in Amphista Therapeutics as it targets neurodegenerative diseases

Dementia Discovery Fund invests in Amphista Therapeutics as it targets neurodegenerative diseases - read this article along with other careers information, tips and advice on BioSpace

Cambridge , Cambridgeshire , United-kingdom , British , Alessio-ciulli , Christian-jung , Bill-gates , Lynn-granito , Tanya-finn , Eli-lilly , Otsuka-astex , Nicola-thompson

Transine Therapeutics Announces Final Closing of its Seed Round at £13.7m to Accelerate its Platform and Portfolio Development

/PRNewswire/ -- Transine Therapeutics ('Transine'), a biotechnology company developing a novel class of therapeutic RNAs based on its pioneering SINEUP®...

Cambridge , Cambridgeshire , United-kingdom , British , Frazer-hall , Christian-jung , Piero-carninci , Bill-gates , Eli-lilly , Sylvie-berrebi , Jan-thirkettle , Otsuka-astex

LoQus23 Therapeutics exits stealth with £11.5 million seed financing from the Dementia Discovery Fund and Novartis Venture Fund

/PRNewswire/ -- LoQus23 Therapeutics Ltd. ('LoQus23'), a company discovering small molecule therapies that target aberrant DNA mismatch repair (MMR) to treat...

Cambridge , Cambridgeshire , United-kingdom , British , Christian-jung , Florian-muellershausen , George-underwood , Bill-gates , Eli-lilly , Sylvie-berrebi , Caroline-benn , Ruth-mckernan-fmedsci

LoQus23 Therapeutics exits stealth with £11.5 million seed financing from the Dementia Discovery Fund and Novartis Venture Fund

- Company targets DNA mismatch repair pathways to slow neurodegeneration in Huntington's Disease and other triplet repeat disorders - LoQus23's structure-based approach focuses

Cambridge , Cambridgeshire , United-kingdom , British , Christian-jung , Florian-muellershausen , George-underwood , Bill-gates , Eli-lilly , Sylvie-berrebi , Caroline-benn , Ruth-mckernan-fmedsci

LoQus23 Therapeutics exits stealth with £11.5 million seed financing from the Dementia Discovery Fund and Novartis Venture Fund

/PRNewswire/ -- LoQus23 Therapeutics Ltd. ('LoQus23'), a company discovering small molecule therapies that target aberrant DNA mismatch repair (MMR) to treat...

Cambridge , Cambridgeshire , United-kingdom , British , Christian-jung , Florian-muellershausen , George-underwood , Bill-gates , Eli-lilly , Sylvie-berrebi , Caroline-benn , Ruth-mckernan-fmedsci

LoQus23 Therapeutics exits stealth with £11.5 million seed financing from the Dementia Discovery Fund and Novartis Venture Fund

LoQus23 Therapeutics exits stealth with £11.5 million seed financing from the Dementia Discovery Fund and Novartis Venture Fund
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Cambridge , Cambridgeshire , United-kingdom , British , Christian-jung , Florian-muellershausen , George-underwood , Bill-gates , Eli-lilly , Sylvie-berrebi , Caroline-benn , Ruth-mckernan-fmedsci